Amazon signals its foray into drug wholesaling


The prospect of Amazon.com Inc. and its business-to-business segment entering the business is beginning to cause far-reaching reverberations for a range of companies, jarring the shares of drugstore chains, drug distributors and pharmacy benefit managers, and potentially precipitating one of the biggest corporate merger deals this year. On Thursday, the pressure was plain to see.



from Biotech News